Jennison Associates
INSM icon

Jennison Associates’s Insmed INSM Stock Holding History

Jennison Associates’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-380,000
Closed -$11.9M – 672
2017
Q3 		$11.9M Buy
380,000
+110,000
+41% +$2.1M 0.01% 465
2017
Q2 		$4.63M Hold
270,000
– – ﹤0.01% 509
2017
Q1 		$4.73M Buy
+270,000
New +$4.16M 0.01% 513

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jennison Associates's INSM Position: Q1 2026 in Review

Jennison Associates increased its Insmed (INSM) stake by 7.5% in Q1 2026, buying an estimated $6.52M and bringing the position to 604,694 shares worth $98.9M. The position accounts for 0.07% of the portfolio, ranked #137.

Jennison Associates first reported a position in INSM in Q3 2014 and has held it in 23 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Jennison Associates held 604,694 shares of Insmed worth $98.9M as of Q1 2026.
  • Jennison Associates bought 42,398 Insmed shares in Q1 2026, an estimated $6.52M.
  • Insmed made up 0.07% of Jennison Associates's portfolio in Q1 2026, its #137 holding.
  • Jennison Associates first reported a position in Insmed in Q3 2014 and has held it in 23 quarters since.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.